SRRK Scholar Rock Holding Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: SRRK

Price (delayed)

$15.35

Market cap

$1.2B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.99

Enterprise value

$1.15B

Scholar Rock is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays ...

Highlights
Scholar Rock Holding's debt has decreased by 11% YoY and by 2.6% QoQ
Scholar Rock Holding's quick ratio has increased by 4.1% from the previous quarter
The equity has grown by 34% from the previous quarter but it has contracted by 13% YoY
The EPS has grown by 12% YoY but it has contracted by 2.1% from the previous quarter
Scholar Rock Holding's gross profit has plunged by 100% YoY
SRRK's revenue has dropped by 100% year-on-year
Sector: Healthcare
Industry: Biotechnology
Website: http://www.scholarrock.com
Peers: NVCR NVAX

Key stats

What are the main financial stats of SRRK
Market
Shares outstanding
77.87M
Market cap
$1.2B
Enterprise value
$1.15B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.92
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$165.79M
EBITDA
-$155.82M
Free cash flow
-$145.28M
Per share
EPS
-$1.99
Free cash flow per share
-$1.74
Book value per share
$3.12
Revenue per share
$0
TBVPS
$3.73
Balance sheet
Total assets
$311.04M
Total liabilities
$85.82M
Debt
$61.82M
Equity
$225.22M
Working capital
$255.45M
Liquidity
Debt to equity
0.27
Current ratio
8.8
Quick ratio
8.62
Net debt/EBITDA
0.27
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-57.1%
Return on equity
-80.5%
Return on invested capital
-76.2%
Return on capital employed
-59.6%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SRRK stock price

How has the Scholar Rock Holding stock price performed over time
Intraday
1.66%
1 week
5.64%
1 month
0.79%
1 year
110.56%
YTD
-18.35%
QTD
-13.57%

Financial performance

How have Scholar Rock Holding's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$171.3M
Net income
-$165.79M
Gross margin
N/A
Net margin
N/A
Scholar Rock Holding's gross profit has plunged by 100% YoY
SRRK's revenue has dropped by 100% year-on-year
The operating income has contracted by 27% YoY and by 4.6% from the previous quarter
The company's net income fell by 23% YoY and by 4.3% QoQ

Growth

What is Scholar Rock Holding's growth rate over time

Valuation

What is Scholar Rock Holding stock price valuation
P/E
N/A
P/B
4.92
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has grown by 12% YoY but it has contracted by 2.1% from the previous quarter
SRRK's price to book (P/B) is 59% more than its last 4 quarters average of 3.1 and 23% more than its 5-year quarterly average of 4.0
The equity has grown by 34% from the previous quarter but it has contracted by 13% YoY
SRRK's revenue has dropped by 100% year-on-year

Efficiency

How efficient is Scholar Rock Holding business performance
The return on equity has dropped by 58% year-on-year and by 9% since the previous quarter
The return on assets has dropped by 53% year-on-year and by 9% since the previous quarter
Scholar Rock Holding's ROIC has decreased by 32% YoY and by 10% from the previous quarter

Dividends

What is SRRK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SRRK.

Financial health

How did Scholar Rock Holding financials performed over time
The total assets is up by 24% since the previous quarter but it is down by 13% year-on-year
The company's total liabilities fell by 12% YoY but it rose by 3.4% QoQ
Scholar Rock Holding's debt is 73% lower than its equity
The equity has grown by 34% from the previous quarter but it has contracted by 13% YoY
The company's debt to equity fell by 29% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.